Next Article in Journal
Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelodysplastic Syndrome Patients
Next Article in Special Issue
Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 2
Previous Article in Journal
Passive Coagulability Assay Based on Coherence-Gated Light Scattering
Previous Article in Special Issue
The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study
Review

The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock

1
Stem Cell Transplant Center, AOU Citta’ Della Salute e Della Scienza, 10100 Turin, Italy
2
Department of Hematology, AOU Citta’ Della Salute e Della Scienza, 10100 Turin, Italy
3
Department of Medical Sciences, University of Turin, 10100 Turin, Italy
*
Author to whom correspondence should be addressed.
Received: 15 October 2020 / Revised: 16 November 2020 / Accepted: 20 November 2020 / Published: 25 November 2020
(This article belongs to the Collection Exclusive Papers of the Editorial Board Members (EBMs) of Hemato)
Bloodstream infection (BSI) and septic shock represent one of the major limiting factors for the successful treatment of patients affected by hematologic malignancies. During the most recent years we have documented a shift in the epidemiology of bacterial infections toward a consistent rise of Gram-negative rods. In addition, the emergence of multi-drug-resistant bacteria is considered a life-threatening condition requiring a multi-disciplinary approach. Aim of present review is to summarize the most recent approaches in terms of anti-microbial prophylaxis and treatment of BSI in hematologic patients with neutropenic fever. View Full-Text
Keywords: bloodstream infections; multi-drug-resistant bacteria; septic shock bloodstream infections; multi-drug-resistant bacteria; septic shock
Show Figures

Figure 1

MDPI and ACS Style

Secreto, C.; Busca, A.; Lupia, T.; Corcione, S.; De Rosa, F.G. The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock. Hemato 2020, 1, 60-76. https://0-doi-org.brum.beds.ac.uk/10.3390/hemato1020010

AMA Style

Secreto C, Busca A, Lupia T, Corcione S, De Rosa FG. The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock. Hemato. 2020; 1(2):60-76. https://0-doi-org.brum.beds.ac.uk/10.3390/hemato1020010

Chicago/Turabian Style

Secreto, Carolina, Alessandro Busca, Tommaso Lupia, Silvia Corcione, and Francesco G. De Rosa 2020. "The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock" Hemato 1, no. 2: 60-76. https://0-doi-org.brum.beds.ac.uk/10.3390/hemato1020010

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop